Newborn affected by maternal use of cocaine
ICD-10 P04.41 is a billable code used to indicate a diagnosis of newborn affected by maternal use of cocaine.
P04.41 refers to newborns who are affected by maternal cocaine use during pregnancy. Cocaine is a powerful stimulant that can cross the placenta and affect fetal development. Infants exposed to cocaine in utero may present with a range of symptoms, including low birth weight, irritability, feeding difficulties, and potential withdrawal symptoms. These infants are at risk for neurodevelopmental issues and may require specialized care in a neonatal intensive care unit (NICU). The effects of cocaine can also be compounded by the use of other substances, such as alcohol and tobacco, which can further impact the newborn's health. It is crucial for healthcare providers to conduct thorough assessments and provide appropriate interventions to support the infant's growth and development. Documentation should include maternal history, substance use patterns, and any observed neonatal symptoms to ensure accurate coding and care planning.
Neonatal documentation must include maternal history, substance use details, and any observed withdrawal symptoms in the newborn.
Common scenarios include infants presenting with irritability, feeding difficulties, or low birth weight due to maternal cocaine use.
Consideration must be given to the potential for co-occurring substance use and the need for multidisciplinary care.
Pediatric documentation should include developmental assessments and follow-up care plans for infants affected by maternal substance use.
Pediatric scenarios may involve ongoing monitoring for developmental delays or behavioral issues stemming from in utero exposure.
Pediatricians should be aware of the long-term implications of maternal substance use on child development.
Used when a newborn requires intensive monitoring and management due to maternal substance exposure.
Documentation must include the severity of the newborn's condition and the interventions provided.
Neonatologists should ensure that all critical care services are well-documented to support billing.
Long-term effects can include developmental delays, behavioral issues, and increased risk for learning disabilities. Continuous monitoring and early intervention are crucial for affected infants.
